sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks H-Phe-ser-oh

H-Phe-ser-oh

CAS No.:
16053-39-7
Catalog Number:
AG00ACJ5
Molecular Formula:
C12H16N2O4
Molecular Weight:
252.2664
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
250mg
≥ 99% (TLC)
1 week
United States
$126
- +
1g
≥ 99% (TLC)
1 week
United States
$221
- +
5g
≥ 99% (TLC)
1 week
United States
$901
- +
Product Description
Catalog Number:
AG00ACJ5
Chemical Name:
H-Phe-ser-oh
CAS Number:
16053-39-7
Molecular Formula:
C12H16N2O4
Molecular Weight:
252.2664
MDL Number:
MFCD00083787
IUPAC Name:
(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-3-hydroxypropanoic acid
InChI:
InChI=1S/C12H16N2O4/c13-9(6-8-4-2-1-3-5-8)11(16)14-10(7-15)12(17)18/h1-5,9-10,15H,6-7,13H2,(H,14,16)(H,17,18)/t9-,10-/m0/s1
InChI Key:
ROHDXJUFQVRDAV-UWVGGRQHSA-N
SMILES:
OC[C@@H](C(=O)O)NC(=O)[C@H](Cc1ccccc1)N
Properties
Complexity:
290  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Defined Bond Stereocenter Count:
0
Exact Mass:
252.111g/mol
Formal Charge:
0
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
4  
Isotope Atom Count:
0
Molecular Weight:
252.27g/mol
Monoisotopic Mass:
252.111g/mol
Rotatable Bond Count:
6  
Topological Polar Surface Area:
113A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-3.7  
Literature
Title Journal
Affinity and translocation relationships via hPEPT1 of H-X aa-Ser-OH dipeptides: evaluation of H-Phe-Ser-OH as a pro-moiety for ibuprofen and benzoic acid prodrugs. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20110201
L-Isoleucyl-L-serine 0.33-hydrate, L-phenylalanyl-L-serine and L-methionyl-L-serine 0.34-hydrate. Acta crystallographica. Section C, Crystal structure communications 20060101
Concentration-dependent atypical intestinal absorption of cyclic phenylalanylserine: small intestine acts as an interface between the body and ingested compounds. Biological & pharmaceutical bulletin 20031101
Concentration-dependent preferences of absorptive and excretive transport cause atypical intestinal absorption of cyclic phenylalanylserine: small intestine acts as an interface between the body and ingested compounds. Research communications in molecular pathology and pharmacology 20020101
Properties